Skip to main content
Colgate Palmolive Co (CL)
Household and Personal Products Consumer Staples
Stock AI

Colgate-Palmolive Reports Strong Q2 2024 Results Amidst Challenging Conditions

Last updated: July 26, 2024
Taurigo

Colgate-Palmolive Company, a leader in consumer goods with a diverse portfolio in oral care, personal care, and pet nutrition, has released its financial report for the second quarter of 2024. The results highlight a robust performance, driven by strategic growth initiatives and increased consumer demand, despite facing various global economic challenges.

1. Overview of Q2 Performance

For the second quarter of 2024, Colgate-Palmolive reported net sales of $5.058 billion, reflecting a 4.9% increase compared to the same period last year. This growth was attributed to a combination of volume growth of 4.7% and a net selling price increase of 4.2%, although it was partially offset by negative foreign exchange impacts of 4.1%.

Key Financial Highlights

  • Net Income: The company's net income attributable to Colgate-Palmolive increased by 45.7% to $731 million, compared to $502 million in the prior year.
  • Earnings Per Share: Adjusted earnings per share rose significantly, showcasing improved profitability amid rising operational costs.
  • Gross Profit Margin: The gross profit margin improved to 60.8%, up from 57.8% in Q2 2023, driven by higher sales and operational efficiencies.
Income Statement of Colgate Palmolive Co
Jul 2023 Jul 2024
Net Income
1.49B2.84B
Net Income to Non-controlling Interest
176M163M
Profit
1.67B3.00B
Net Income Continuing
1.67B3.00B
Income Tax Expense
799M918M
Pretax Income
2.47B3.92B
Non-operating Income
-560M-319M
Operating Income
3.03B4.24B
Revenue
18.67B19.98B
Other Operating Income
-75M-212M
Costs and Expenses
15.56B15.53B
Cost of Revenue
8.05B8.05B
Operating Expenses
7.51B7.48B
Impairment Expense
721M0
Selling, General & Administrative
6.79B7.48B

2. Segment Performance

Colgate-Palmolive operates primarily in two product segments: Oral, Personal, and Home Care, and Pet Nutrition. Both segments demonstrated strong growth in the second quarter.

Oral, Personal, and Home Care

This segment generated net sales of $3.944 billion, marking a 4.7% increase from Q2 2023. Organic sales showed an impressive increase of 9.8%, driven by successful marketing campaigns and new product launches.

Pet Nutrition

The Pet Nutrition segment reported net sales of $1.114 billion, up 5.5% from the previous year, with organic sales rising by 6.1%. This growth reflects the increasing demand for premium pet products and the strong brand equity of Hill's Pet Nutrition.

3. Geographic Distribution of Sales

Colgate-Palmolive's diverse geographic presence is a significant asset, with approximately 45% of net sales coming from emerging markets. The following highlights the sales growth across various regions:

  • North America: Net sales increased by 2.5% to $1.002 billion.
  • Latin America: Sales surged by 7.6% to $1.267 billion, driven by both volume and price increases.
  • Europe: Net sales rose by 6.2% to $720 million.
  • Asia Pacific: Sales grew by 2.6% to $682 million.
  • Africa/Eurasia: The region saw a 2.2% increase in sales to $273 million.
Balance Sheet of Colgate Palmolive Co
Jul 2023 Jul 2024
Total Assets
16.22B16.48B
Total Current Assets
5.43B5.64B
Cash and Equivalents
819M1.11B
Net Inventories
2.03B1.92B
Accounts Receivable
1.65B1.82B
Other Current Assets
923M789M
Total Non-current Assets
10.79B10.83B
Intangible Assets
5.27B5.13B
Non-current Deferred Tax Assets
186M214M
Net PP&E
4.43B4.39B
Other Non-current Assets
899M1.09B
Total Liabilities and Equity
16.22B16.48B
Total Liabilities
15.91B15.99B
Total Current Liabilities
4.63B5.35B
Accounts Payable and Accrued Liabilities
4.59B4.82B
Current Debt
35M530M
Total Non-current Liabilities
11.28B10.64B
Long-term Debt
8.95B8.14B
Non-current Deferred Tax Liabilities
363M355M
Other Non-current Liabilities
1.96B2.14B
Total Equity and Non-controlling Interests
315M482M
Total Equity
-64M123M
Non-controlling Interests
379M359M

4. Operational Efficiency and Cost Management

The company's commitment to operational efficiency is evident in its cost management strategies. Selling, general, and administrative expenses rose by 10% to $1.939 billion in Q2 2024, driven primarily by increased investments in advertising and overhead expenses. However, as a percentage of net sales, these expenses only increased by 170 basis points to 38.3%, reflecting improved operational leverage.

5. Challenges on the Horizon

Despite the positive financial results, Colgate-Palmolive faces several challenges, including:

  • Macroeconomic Pressures: High inflation and interest rates pose risks to consumer spending.
  • Foreign Currency Volatility: Fluctuations in foreign currencies, particularly in markets like Argentina and Türkiye, could impact profitability.
  • Raw Material Costs: Increased costs for raw and packaging materials are expected to persist, affecting margins.
  • Competitive Pressures: The landscape of consumer goods continues to be competitive, necessitating ongoing innovation and marketing efforts.

6. Conclusion

Colgate-Palmolive's second quarter results reflect a strong operational performance amidst a challenging economic landscape. The company's strategic focus on innovation, efficiency, and market expansion has positioned it well for future growth. As it navigates the difficulties ahead, stakeholders will closely monitor its ability to maintain momentum and adapt to changing market conditions.

With a commitment to sustainability and community impact, Colgate-Palmolive continues to strive for profitable growth while enhancing its market presence globally.

Cash Flow Statement of Colgate Palmolive Co
Jul 2023 Jul 2024
Net Change in Cash
-39M291M
Effect of Exchange Rate Changes
-59M-16M
Net Cash from Operating Activities
3.09B3.95B
Operating Profit
1.67B3.00B
Adjustment to Operating Profit
1.42B957M
Net Cash from Investing Activities
-1.55B-608M
Business & Interest in Affiliates
719M0
Investments
136M-10M
Productive Assets
696M601M
Other Investing Activities
-6M-17M
Net Cash from Financing Activities
-1.52B-3.04B
Debt
824M-255M
Dividends
1.72B1.76B
Equity Issuance/Repurchase
-627M-990M
Other Financing Activities
5M-30M
You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.